A patient at the Royal Manchester Children’s Hospital (RMCH) was the first in the UK to receive a convalescent plasma transfusion, after being selected through the RECOVERY COVID-19 research study.
Our first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).
As part of the NIHR Your Path in Research campaign, we are shining a spotlight on Emma Charnock, a Senior Paediatric Oncology Research Nurse at Royal Manchester Children’s Hospital.
Congratulations are in order for many of our Research and Innovation team members, with five wins for MFT at the 2019 NIHR Greater Manchester Clinical Research Awards last night.